Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Article Contents Understanding the Retatrutide Timeline The 4 Distinct Phases of Treatment Weeks 1-4: The Adjustment Phase Weeks 5-8: The Challenge Phase Weeks 9-12: The Turning Point Weeks 13-24: The Momentum Phase Weeks 25-36: The Steady State Phase Weeks 37-48: The Plateau Phase What Actually Determines Your Timeline How This Compares to Tirzepatide and Semaglutide Canadian Access and Timeline Considerations Frequently Asked Questions Understanding the Retatrutide Timeline Clinical trials tracked 338 participants through 48 weeks of Retatrutide treatment at the 12mg maintenance dose
All IV therapies are subject to medical consultation and suitability
In Phase 2 trials, individuals receiving higher doses of Retatrutide experienced body weight reductions averaging up to 24% within a 48-week period
MS2 non-competitive internal control (MS2 IC) MS2 IC is a non-infectious recombinant MS2 phage prepared in-house so that it contains MS2 maturase and coating protein gene and a truncated MS2 replicase gene
Figure 1 3.2
While these findings dont directly translate to humans, they raise legitimate concerns about reproductive health, endocrine disruption, and metabolic stress with prolonged, high-dose usage
